-
Complicated Skin And Soft Tissue Infections Clinical Trials, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, Pipeline Analysis Micurx Pharmaceuticals Inc., Basilea Pharmaceutica
07 Aug 2025 00:56 GMT
… often demand prompt medical attention and hospitalization. … treatment options.
Leading companies such as MicuRx Pharmaceuticals Inc., Basilea Pharmaceutica … Contezolid (MRX-I), Ceftobiprole medocaril, and several … Phase III clinical trials.
DelveInsight's …
-
Antibiotic-resistant bacteria a continuing medical concern
27 Jul 2025 21:40 GMT
… for the medical field and pharmaceutical industry.
Penicillin … an infectious disease doctor with Community Health Network … and Drug Administration: aztreonam, piperacillin-tazobactam, levofloxacin, ceftobiprole and … University as a biotechnology professor, but …
-
The Cephalosporin Drugs Market Analysis 2025: Insights for Long-Term Investment & Planning
16 Jun 2025 11:23 GMT
… Mankind Pharma Limited, Aristo Pharmaceuticals Ltd, Hetero Drugs Ltd, Covalent Laboratories Private … as gram-negative bacterial infection treatment strategies to confront antimicrobial … 5 By Fifth Generation: Ceftaroline, Ceftobiprole.
How's The …
-
FDA Grants Priority Review for Zoliflodacin New Drug Application for the Treatment of Uncomplicated Gonorrhea and Assigns Target PDUFA Date of December 15, 2025
12 Jun 2025 11:10 GMT
… S. Food and Drug Administration (FDA) has granted … , the South African Medical Research Council (SAMRC) … treatment of uncomplicated gonorrhea, and La Jolla Pharmaceutical Company … also markets ZEVTERA® (ceftobiprole), an advanced-generation cephalosporin …
-
Innoviva Specialty Therapeutics Receives FDA New Drug Application Acceptance for Zoliflodacin, a First-in-Class Oral Antibiotic for Uncomplicated Gonorrhea in Adults
10 Jun 2025 10:08 GMT
… S. Food and Drug Administration (FDA) has accepted its … trials include a pivotal Phase 3 clinical trial which … ensure treatment is available to address unmet medical needs … Pharmaceutica Ltd, Allschwil for the commercialization of ZEVTERA® (ceftobiprole), …
-
Ceftobiprole Launches Commercially in US
20 May 2025 19:12 GMT
… therapy in 2 years, addressing drug-resistant pathogens that pose significant … measure of efficacy for this trial was the overall success (defined … antibacterial treatment or unplanned surgery. Of the subjects who received ceftobiprole, 91 …
-
ZEVTERA® (ceftobiprole), an Advanced-Generation Cephalosporin Antibiotic Now Commercially Available in the U.S. to Treat Three Types of Bacterial Infections
20 May 2025 10:07 GMT
… S. Food and Drug Administration (FDA) approved advanced- … was developed by Basilea Pharmaceutica Ltd, Allschwil (“Basilea … a substantial medical need for treatments targeting Staphylococcus … , et al. Ceftobiprole for treatment of complicated Staphylococcus …
-
Basilea announces commercial availability of antibiotic Zevtera® (ceftobiprole) in the United States
20 May 2025 05:15 GMT
… Food and Drug Administration (FDA) for the treatment of adult … a high medical need for treatments targeting Staphylococcus … patients in clinical trials. Serious and occasionally … Pharmaceutica Ltd, Allschwil for the commercialization of ZEVTERA® (ceftobiprole …
-
Basilea Pharmaceutica announces commercial availability of antibiotic Zevtera in United States
21 May 2025 05:54 GMT
Basilea Pharmaceutica Ltd, Allschwil, a … that its antibiotic Zevtera (ceftobiprole medocaril for injection) is … States Food and Drug Administration (FDA) for the treatment of adult … is a high medical need for treatments targeting Staphylococcus aureus …
-
Basilea reports presentation of new data for fosmanogepix, isavuconazole (Cresemba®) and ceftobiprole (Zevtera®) at ESCMID Global 2025
16 Apr 2025 05:15 GMT
… ceftobiprole (Zevtera®). Dr. Marc Engelhardt, Chief Medical … standard-of-care treatment, experienced treatment-limiting toxicities, … from Three Phase 3 Trials and Covariate Exploration … expressions concerning Basilea Pharmaceutica Ltd, Allschwil and …
About
© 1995-2025